Inhibitors of influenza viruses replication

Abstract Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wannamaker, M. Woods, Gu, Wenxin, Deng, Hongbo, Wang, Tiansheng, Court, John J, Ledeboer, Mark W, Lin, Chao, Ledford, Brian, Bandarage, Upul K, Drutu, Ioana, Duffy, John P, Gao, Huai, Jacobs, Dylan H, Farmer, Luc, Kwong, Ann Dak-Yee, Bethiel, Randy S, Kennedy, Joseph M, Jones, Steven, Clark, Michael P, Charifson, Paul, Jiang, Min, Perola, Emanuele, Germann, Ursula A, Maltais, Francois, Zhou, Yi, Byrn, Randal, Salituro, Francesco G
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Wannamaker, M. Woods
Gu, Wenxin
Deng, Hongbo
Wang, Tiansheng
Court, John J
Ledeboer, Mark W
Lin, Chao
Ledford, Brian
Bandarage, Upul K
Drutu, Ioana
Duffy, John P
Gao, Huai
Jacobs, Dylan H
Farmer, Luc
Kwong, Ann Dak-Yee
Bethiel, Randy S
Kennedy, Joseph M
Jones, Steven
Clark, Michael P
Charifson, Paul
Jiang, Min
Perola, Emanuele
Germann, Ursula A
Maltais, Francois
Zhou, Yi
Byrn, Randal
Salituro, Francesco G
description Abstract Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2016204286BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2016204286BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2016204286BB23</originalsourceid><addsrcrecordid>eNrjZND2zMvITMosyS8qVshPU8jMS8spTc2rSlQoyywqLU4tVihKLcjJTE4syczP42FgTUvMKU7lhdLcDCpuriHOHrqpBfnxqcUFicmpeakl8Y6hRgaGZkYGJkYWZk5ORsZEKgMAl8crUQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Inhibitors of influenza viruses replication</title><source>esp@cenet</source><creator>Wannamaker, M. Woods ; Gu, Wenxin ; Deng, Hongbo ; Wang, Tiansheng ; Court, John J ; Ledeboer, Mark W ; Lin, Chao ; Ledford, Brian ; Bandarage, Upul K ; Drutu, Ioana ; Duffy, John P ; Gao, Huai ; Jacobs, Dylan H ; Farmer, Luc ; Kwong, Ann Dak-Yee ; Bethiel, Randy S ; Kennedy, Joseph M ; Jones, Steven ; Clark, Michael P ; Charifson, Paul ; Jiang, Min ; Perola, Emanuele ; Germann, Ursula A ; Maltais, Francois ; Zhou, Yi ; Byrn, Randal ; Salituro, Francesco G</creator><creatorcontrib>Wannamaker, M. Woods ; Gu, Wenxin ; Deng, Hongbo ; Wang, Tiansheng ; Court, John J ; Ledeboer, Mark W ; Lin, Chao ; Ledford, Brian ; Bandarage, Upul K ; Drutu, Ioana ; Duffy, John P ; Gao, Huai ; Jacobs, Dylan H ; Farmer, Luc ; Kwong, Ann Dak-Yee ; Bethiel, Randy S ; Kennedy, Joseph M ; Jones, Steven ; Clark, Michael P ; Charifson, Paul ; Jiang, Min ; Perola, Emanuele ; Germann, Ursula A ; Maltais, Francois ; Zhou, Yi ; Byrn, Randal ; Salituro, Francesco G</creatorcontrib><description>Abstract Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180201&amp;DB=EPODOC&amp;CC=AU&amp;NR=2016204286B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20180201&amp;DB=EPODOC&amp;CC=AU&amp;NR=2016204286B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Wannamaker, M. Woods</creatorcontrib><creatorcontrib>Gu, Wenxin</creatorcontrib><creatorcontrib>Deng, Hongbo</creatorcontrib><creatorcontrib>Wang, Tiansheng</creatorcontrib><creatorcontrib>Court, John J</creatorcontrib><creatorcontrib>Ledeboer, Mark W</creatorcontrib><creatorcontrib>Lin, Chao</creatorcontrib><creatorcontrib>Ledford, Brian</creatorcontrib><creatorcontrib>Bandarage, Upul K</creatorcontrib><creatorcontrib>Drutu, Ioana</creatorcontrib><creatorcontrib>Duffy, John P</creatorcontrib><creatorcontrib>Gao, Huai</creatorcontrib><creatorcontrib>Jacobs, Dylan H</creatorcontrib><creatorcontrib>Farmer, Luc</creatorcontrib><creatorcontrib>Kwong, Ann Dak-Yee</creatorcontrib><creatorcontrib>Bethiel, Randy S</creatorcontrib><creatorcontrib>Kennedy, Joseph M</creatorcontrib><creatorcontrib>Jones, Steven</creatorcontrib><creatorcontrib>Clark, Michael P</creatorcontrib><creatorcontrib>Charifson, Paul</creatorcontrib><creatorcontrib>Jiang, Min</creatorcontrib><creatorcontrib>Perola, Emanuele</creatorcontrib><creatorcontrib>Germann, Ursula A</creatorcontrib><creatorcontrib>Maltais, Francois</creatorcontrib><creatorcontrib>Zhou, Yi</creatorcontrib><creatorcontrib>Byrn, Randal</creatorcontrib><creatorcontrib>Salituro, Francesco G</creatorcontrib><title>Inhibitors of influenza viruses replication</title><description>Abstract Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZND2zMvITMosyS8qVshPU8jMS8spTc2rSlQoyywqLU4tVihKLcjJTE4syczP42FgTUvMKU7lhdLcDCpuriHOHrqpBfnxqcUFicmpeakl8Y6hRgaGZkYGJkYWZk5ORsZEKgMAl8crUQ</recordid><startdate>20180201</startdate><enddate>20180201</enddate><creator>Wannamaker, M. Woods</creator><creator>Gu, Wenxin</creator><creator>Deng, Hongbo</creator><creator>Wang, Tiansheng</creator><creator>Court, John J</creator><creator>Ledeboer, Mark W</creator><creator>Lin, Chao</creator><creator>Ledford, Brian</creator><creator>Bandarage, Upul K</creator><creator>Drutu, Ioana</creator><creator>Duffy, John P</creator><creator>Gao, Huai</creator><creator>Jacobs, Dylan H</creator><creator>Farmer, Luc</creator><creator>Kwong, Ann Dak-Yee</creator><creator>Bethiel, Randy S</creator><creator>Kennedy, Joseph M</creator><creator>Jones, Steven</creator><creator>Clark, Michael P</creator><creator>Charifson, Paul</creator><creator>Jiang, Min</creator><creator>Perola, Emanuele</creator><creator>Germann, Ursula A</creator><creator>Maltais, Francois</creator><creator>Zhou, Yi</creator><creator>Byrn, Randal</creator><creator>Salituro, Francesco G</creator><scope>EVB</scope></search><sort><creationdate>20180201</creationdate><title>Inhibitors of influenza viruses replication</title><author>Wannamaker, M. Woods ; Gu, Wenxin ; Deng, Hongbo ; Wang, Tiansheng ; Court, John J ; Ledeboer, Mark W ; Lin, Chao ; Ledford, Brian ; Bandarage, Upul K ; Drutu, Ioana ; Duffy, John P ; Gao, Huai ; Jacobs, Dylan H ; Farmer, Luc ; Kwong, Ann Dak-Yee ; Bethiel, Randy S ; Kennedy, Joseph M ; Jones, Steven ; Clark, Michael P ; Charifson, Paul ; Jiang, Min ; Perola, Emanuele ; Germann, Ursula A ; Maltais, Francois ; Zhou, Yi ; Byrn, Randal ; Salituro, Francesco G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2016204286BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2018</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Wannamaker, M. Woods</creatorcontrib><creatorcontrib>Gu, Wenxin</creatorcontrib><creatorcontrib>Deng, Hongbo</creatorcontrib><creatorcontrib>Wang, Tiansheng</creatorcontrib><creatorcontrib>Court, John J</creatorcontrib><creatorcontrib>Ledeboer, Mark W</creatorcontrib><creatorcontrib>Lin, Chao</creatorcontrib><creatorcontrib>Ledford, Brian</creatorcontrib><creatorcontrib>Bandarage, Upul K</creatorcontrib><creatorcontrib>Drutu, Ioana</creatorcontrib><creatorcontrib>Duffy, John P</creatorcontrib><creatorcontrib>Gao, Huai</creatorcontrib><creatorcontrib>Jacobs, Dylan H</creatorcontrib><creatorcontrib>Farmer, Luc</creatorcontrib><creatorcontrib>Kwong, Ann Dak-Yee</creatorcontrib><creatorcontrib>Bethiel, Randy S</creatorcontrib><creatorcontrib>Kennedy, Joseph M</creatorcontrib><creatorcontrib>Jones, Steven</creatorcontrib><creatorcontrib>Clark, Michael P</creatorcontrib><creatorcontrib>Charifson, Paul</creatorcontrib><creatorcontrib>Jiang, Min</creatorcontrib><creatorcontrib>Perola, Emanuele</creatorcontrib><creatorcontrib>Germann, Ursula A</creatorcontrib><creatorcontrib>Maltais, Francois</creatorcontrib><creatorcontrib>Zhou, Yi</creatorcontrib><creatorcontrib>Byrn, Randal</creatorcontrib><creatorcontrib>Salituro, Francesco G</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Wannamaker, M. Woods</au><au>Gu, Wenxin</au><au>Deng, Hongbo</au><au>Wang, Tiansheng</au><au>Court, John J</au><au>Ledeboer, Mark W</au><au>Lin, Chao</au><au>Ledford, Brian</au><au>Bandarage, Upul K</au><au>Drutu, Ioana</au><au>Duffy, John P</au><au>Gao, Huai</au><au>Jacobs, Dylan H</au><au>Farmer, Luc</au><au>Kwong, Ann Dak-Yee</au><au>Bethiel, Randy S</au><au>Kennedy, Joseph M</au><au>Jones, Steven</au><au>Clark, Michael P</au><au>Charifson, Paul</au><au>Jiang, Min</au><au>Perola, Emanuele</au><au>Germann, Ursula A</au><au>Maltais, Francois</au><au>Zhou, Yi</au><au>Byrn, Randal</au><au>Salituro, Francesco G</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Inhibitors of influenza viruses replication</title><date>2018-02-01</date><risdate>2018</risdate><abstract>Abstract Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2016204286BB2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Inhibitors of influenza viruses replication
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T10%3A04%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Wannamaker,%20M.%20Woods&rft.date=2018-02-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2016204286BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true